Cargando…
Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651251/ https://www.ncbi.nlm.nih.gov/pubmed/34901886 http://dx.doi.org/10.1016/S2665-9913(21)00372-6 |
_version_ | 1784611363978477568 |
---|---|
author | Barbhaiya, Medha Levine, Jonah M Bykerk, Vivian P Mandl, Lisa A |
author_facet | Barbhaiya, Medha Levine, Jonah M Bykerk, Vivian P Mandl, Lisa A |
author_sort | Barbhaiya, Medha |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8651251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86512512021-12-08 Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination Barbhaiya, Medha Levine, Jonah M Bykerk, Vivian P Mandl, Lisa A Lancet Rheumatol Comment Elsevier Ltd. 2022-02 2021-12-08 /pmc/articles/PMC8651251/ /pubmed/34901886 http://dx.doi.org/10.1016/S2665-9913(21)00372-6 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Comment Barbhaiya, Medha Levine, Jonah M Bykerk, Vivian P Mandl, Lisa A Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination |
title | Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination |
title_full | Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination |
title_fullStr | Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination |
title_full_unstemmed | Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination |
title_short | Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination |
title_sort | immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of covid-19 vaccination |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651251/ https://www.ncbi.nlm.nih.gov/pubmed/34901886 http://dx.doi.org/10.1016/S2665-9913(21)00372-6 |
work_keys_str_mv | AT barbhaiyamedha immunomodulatoryandimmunosuppressivemedicationmodificationamongpatientswithrheumaticdiseasesatthetimeofcovid19vaccination AT levinejonahm immunomodulatoryandimmunosuppressivemedicationmodificationamongpatientswithrheumaticdiseasesatthetimeofcovid19vaccination AT bykerkvivianp immunomodulatoryandimmunosuppressivemedicationmodificationamongpatientswithrheumaticdiseasesatthetimeofcovid19vaccination AT mandllisaa immunomodulatoryandimmunosuppressivemedicationmodificationamongpatientswithrheumaticdiseasesatthetimeofcovid19vaccination |